1. Home
  2. WSR vs ARVN Comparison

WSR vs ARVN Comparison

Compare WSR & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Whitestone REIT

WSR

Whitestone REIT

HOLD

Current Price

$16.64

Market Cap

835.1M

Sector

Real Estate

ML Signal

HOLD

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$11.05

Market Cap

781.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WSR
ARVN
Founded
1998
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
835.1M
781.0M
IPO Year
2002
2018

Fundamental Metrics

Financial Performance
Metric
WSR
ARVN
Price
$16.64
$11.05
Analyst Decision
Buy
Buy
Analyst Count
3
20
Target Price
$16.50
$15.35
AVG Volume (30 Days)
236.4K
794.8K
Earning Date
04-29-2026
04-30-2026
Dividend Yield
3.44%
N/A
EPS Growth
31.94
58.84
EPS
0.95
N/A
Revenue
$160,859,000.00
$262,600,000.00
Revenue This Year
$2.15
N/A
Revenue Next Year
$3.95
N/A
P/E Ratio
$17.43
N/A
Revenue Growth
4.26
N/A
52 Week Low
$11.43
$5.90
52 Week High
$16.65
$14.22

Technical Indicators

Market Signals
Indicator
WSR
ARVN
Relative Strength Index (RSI) 66.23 45.54
Support Level $15.90 $11.07
Resistance Level N/A $14.03
Average True Range (ATR) 0.31 0.67
MACD -0.01 0.06
Stochastic Oscillator 97.44 54.93

Price Performance

Historical Comparison
WSR
ARVN

About WSR Whitestone REIT

Whitestone REIT is a real estate investment trust (REIT) that owns and operates commercial properties in culturally diverse metropolitan markets. The company's primary business objective is to increase shareholder value by acquiring, owning, and operating Community Centered Properties. Its property portfolio includes retail and mixed-use properties located in business-friendly locations in and around Austin, Scottsdale, Dallas, Houston, Phoenix, Arizona, and San Antonio. The properties are convenience-focused: merchandised with a mix of service-oriented tenants providing food (restaurants and grocers), self-care (health and fitness), services (financial and logistics), education, and entertainment to the surrounding communities.

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

Share on Social Networks: